UKPDS 19: Heterogeneity in NIDDM: Separate contributions of IRS-1 and β3-adrenergic-receptor mutations to insulin resistance and obesity respectively with no evidence for glycogen synthase gene mutations

Diabetologia

Volumn 39, Issue 12, 1996, Pages 1505-1511

  Zhang, Y ^a   Wat, N ^a   Stratton, I M ^a   Warren Perry, M G ^a   Orho, M ^b   Groop, L ^b   Turner, R C ^a  

^a RADCLIFFE INFIRMARY   (United Kingdom)

^b LUND UNIVERSITY   (Sweden)

Author keywords

3 adrenergic receptor; dyslipidaemia; glycogen synthase; insulin receptor substrate 1; insulin resistance; lipoprotein lipase

Indexed keywords

BETA 3 ADRENERGIC RECEPTOR; GLYCOGEN SYNTHASE; INSULIN RECEPTOR; LIPOPROTEIN LIPASE;

ADULT; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; DYSLIPIDEMIA; GENETIC HETEROGENEITY; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MUTATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL;

ADULT; ALLELES; BASE SEQUENCE; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; DNA PRIMERS; GLYCOGEN SYNTHASE; GREAT BRITAIN; HUMANS; HYPERLIPIDEMIAS; INSULIN RESISTANCE; LIPOPROTEIN LIPASE; MIDDLE AGED; MUTATION; OBESITY; PHENOTYPE; PHOSPHOPROTEINS; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PREVALENCE; PROSPECTIVE STUDIES; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, ADRENERGIC, BETA-3;

EID: 0029857775     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250050605     Document Type: Article

References (49)

1. DeFronzo RA, Bonadonna RC, Ferrannini E (1992) Pathogenesis of NIDDM: a balanced overview. Diabetes Care 15: 318-368
2. Yki-Jarvinen H (1995) Role of insulin resistance in the pathogenesis of NIDDM. Diabetologia 38: 1378-1388
3. Vaag A, Henriksen JE, Madsbad S, Holm N, Beck-Nielsen H (1995) Insulin secretion, insulin action, and hepatic glucose production in identical twins discordant for non-independent diabetes mellitus. J Clin. Inves 2: 690-698
4. Cook JTE, Shields DC, Page RCL et al. (1993) Segregation analysis of type 2 diabetes in Caucasian families. Diabetologia 37: 1231-1240
5. McCarthy M, Froguel P, Hitman G (1994) The genetics of non-insulin-dependent diabetes mellitus: tools and aims. Diabetologia 37: 959-968
6. Gauguier D, Froguel P, Parent V et al. (1996) Chromosomal mapping of genetic loci associated with non-insulin dependent diabetes mellitus in the GK rat. Nat Genet 12: 1-9
7. Barrett-Connor E (1989) Epidemiology, obesity and non-insulin-dependent diabetes mellitus. Epidemiol Rev 11: 172-181
8. Knowler WC, Pettitt D, Saad M (1991) Obesity in the Pima Indians: its magnitude and relationship with diabetes. Am J Clin Nutr 53 [Suppl] 1543S-1551S
9. Taylor SI, Cama A, Accili A (1988) Molecular genetics of insulin resistant diabetes mellitus. J Clin Endocrinol Metab 73: 1158-1163
10. Almind K, Vestergaard H, Hansen T, Echwald S, Pedersen O (1993) Aminoacid polymorphisms of insulin receptor substrate-1 in non-insulin-dependent diabetes mellitus. Lancet 342: 828-832
11. Laakso M, Malkki M, Kekalainen P, Kuusisto J, Deeb SS (1994) Insulin receptor substrate-1 variants in non-insulin-dependent diabetes. J Clin Invest 94: 1141-1146
12. Hitman GA, Hawarami K, McCarthy MI et al. (1995) Insulin receptor substrate-1 gene mutations in NIDDM; implications for the study of polygenic disease. Diabetologia 38: 481-486
13. Clausen JO, Hansen T, Bjcrbaek et al. (1995) Insulin resistance: interactions between obesity and a common variant of insulin receptor substrate-1. Lancet 346: 397-402
14. Imai Y, Fusco A, Suzuki Y, Lesniak M et al. (1994) Variant sequences of insulin receptor substrate-1 in patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 79: 1655-1658
15. Ura S, Araki E, Kishikawa H et al. (1996) Molecular scanning of the insulin receptor substrate-1 (IRS-1) gene in Japanese patients with NIDDM: identification of five novel polymorphisms. Diabetologia 39: 600-608
16. Groop, LC, Kankuri M, Schalin-Jantti C et al. (1993) Association between polymorphism of the glycogen synthase gene and non-insulin-dependent diabetes mellitus. N Engl J Med 328: 10-14
17. Kadowaki T, Kadowaki H, Yazaki Y (1993) Polymorphism of the glycogen synthase gene and non-insulin-dependent diabetes mellitus. N Engl J Med 328: 1568-1569
18. Widen E, Lehto M, Kanninen T, Walston J, Shuldiner AR, Groop L (1995) Association of a polymorphism in the β3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns. N Engl J Med 333: 348-351
19. Walston J, Silver K, Bogardus C et al. (1995) Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the β3-adrenergic-receptor gene. N Engl J Med 333: 343-347
20. Clement K, Vaisse C, Manning BS et al. (1995) Genetic variation in the β3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. N Engl J Med 333: 352-354
21. Kadowaki H, Yasuda K, Iwamoto K et al. (1995) A mutation in the β3-adrenergic receptor gene is associated with obesity and hyperinsulinemia in Japanese subjects. Biochem Biophys Res Commun 215: 555-560
22. Fujisawa T, Ikegami H, Yamato E et al. (1996) Association of Trp64Arg mutation of the β3-adrenergic receptor with NIDDM and body weight gain. Diabetologia 39: 349-352
23. Sun XJ, Rothenberg P, Kahn CR et al. (1991) Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature 352: 73-77
24. Rothenberg P, Lane WS, Karasik A, Backer J, White MF, Kahn CR (1991) Purification and partial sequence analysis of pp185: the major cellular substrate of the insulin receptor tyrosine kinase. J Biol Chem 266: 8302-8311
25. Hager J, Zouali H, Velho G, Froguel P (1993) Insulin receptor substrate (IRS-1) gene polymorphisms in French NIDDM families. Lancet 342: 1430
26. Shimokawa K, Kadowaki H, Sakura H et al. (1994) Molecular scanning of the glycogen synthase and insulin receptor substrate-1 genes in Japanese subjects with non-insulin-dependent diabetes mellitus. Bioch Biophys Res Commu 202: 463-469
27. DeFronzo RA (1988) The triumvirate β-cell, muscle, liver: a collusion responsible for NIDDM. Diabetes 37: 667-687
28. Ferrannini E, Haffner SM, Mitchell BD, Stern MP (1991) Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 34: 416-412
29. Marin P, Andersson B, Ottosson M et al. (1992) The morphology and metabolism of intraabdominal adipose tissue in men. Metabolism 41: 1242-1248
30. Krief S, Lönnqvist F, Raimbault S et al. (1993) Tissue distribution of β3-adrenergic receptor mRNA in man. J Clin Invest 91: 344-349
31. Lönnqvist F, Thörne A, Nilseil K, Hoffstedt J, Arner P (1995) A pathogenetic role of visceral fat β3-adrenergic receptor in obesity. J Clin Invest 95: 1109-1116
32. Colberg SR, Simoneau JA, Thaete FL, Kelley DE (1995) Skeletal muscle utilization of free fatty acids in women with visceral obesity. J Clin invest 95: 1846-1853
33. Vaag A, Henriksen JE, Beck-Nielsen H (1992) Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus. J Clin Invest 89: 782-788
34. Schalin-Jantti C, Harkonen M, Groop LC (1992) Impaired activation of glycogen synthase in people at increased risk for developing NIDDM. Diabetes 41: 598-604
35. Orho M, Nikula-Ijas P, Schalin-Jantti C, Permutt A, Groop L (1995) Isolation and characterization of the human muscle glucogens synthase gene. Diabetes 44: 1099-1105
36. Taskinen MR, Nikkila EA (1981) High density lipoprotein subtractions in relation to lipoprotein lipase activity of tissues in man-evidence for reciprocal regulation of HDL 2 and HDL 3 levels by lipoprotein lipase. Clin Chim Acta 115: 63-71
37. Blades B, Vega GL, Grundy SM (1993) Activities of lipoprotein lipase and triglyceride lipase in postheparin plasma of patients with low concentrations of HDL cholesterol. Art Thromb 13: 8:1227-1235
38. Reymer PWA, Gagne E, Groenemeyer BE et al. (1995) A lipoprotein lipase mutation (Asn291Ser) is associated with reduced HDL cholesterol levels in premature atherosclerosis. Nature Genetics 10: 28-34
39. UK Prospective Diabetes Study (UKPDS) VIII (1991): Study design, progress and performance. Diabetologia 34: 877-890
40. UK Prospective Diabetes Study Group (1994) UKPDS XI: biochemical risk factors in type 2 diabetic patients at diagnosis compared with age-matched normal subjects. Diabet Med 11: 534-544
41. Stoffel M, Espinosa III R, Keller SR, Lienhard GE, Le Beau MM, Bell GI (1993) Human insulin receptor substrate-1 gene (IRS1) chromosomal localization to 2q35-q36.1 and identification of a simple tandem repeat DAN polymorphism. Diabetologia 36: 335-337
42. Vionnet N, Bell GI (1993) Identification of a simple tandem repeat DNA polymorphism in the human glycogen synthase gene and linkage to five markers on chromosome 19q. Diabetes 42: 930-932
43. Giacobino JP (1995) β3-adrenoceptor an update. Eur J Endocrinol 132: 377-385
44. Vestergaard H, Lund S, Larsen FS, Bjerrum OJ, Pedersen O (1993) Glycogen synthase and phosphofructokinase protein and mRNA levels in skeletal muscle from insulin-resistant patients with non-insulin-dependent diabetes mellitus. J Clin Invest 91: 2342-2350
45. Kuroyama H, Sanke T, Ohagi S, Furuta M, Furuta H, Nanjo K (1994) Simple tandem repeat DNA polymorphism in the human glycogen synthase gene is associated with NIDDM in Japanese subjects. Diabetologia 37: 536-539
46. Zouali H, Velho G, Froguel P (1993) Polymorphism of the glycogen synthase gene and non-insulin-dependent diabetes mellitus. N Engl J Med 328: 1568
47. Ma Y, Ooi T, Liu M et al. (1994) High frequency of mutations in the human lipoprotein lipase gene in pregnancy-induced chylomicronemia: possible association with apolipoprotein E2 isoform. J Lipid Res 35: 1066-1075
48. Hosker JP, Matthews DR, Rudenski AS, Burnett MA, Bown EG, Turner RC (1985) Continuous infusion of glucose with model assessment: measurement of insulin resistance and β-cell function in man. Diabetologia 28: 401-411
49. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419